These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 15302680)
1. In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892. Gopalakrishnan M; Buckner SA; Shieh CC; Fey T; Fabiyi A; Whiteaker KL; Davis-Taber R; Milicic I; Daza AV; Scott VE; Castle NA; Printzenhoff D; London B; Turner SC; Carroll WA; Sullivan JP; Coghlan MJ; Brune ME Br J Pharmacol; 2004 Sep; 143(1):81-90. PubMed ID: 15302680 [TBL] [Abstract][Full Text] [Related]
2. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization. Gopalakrishnan M; Buckner SA; Whiteaker KL; Shieh CC; Molinari EJ; Milicic I; Daza AV; Davis-Taber R; Scott VE; Sellers D; Chess-Williams R; Chapple CR; Liu Y; Liu D; Brioni JD; Sullivan JP; Williams M; Carroll WA; Coghlan MJ J Pharmacol Exp Ther; 2002 Oct; 303(1):379-86. PubMed ID: 12235274 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of a 1,4-dihydropyridine analogue, 9-(3,4-dichlorophenyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (A-184209) as a novelK(ATP) channel inhibitor. Gopalakrishnan M; Miller TR; Buckner SA; Milicic I; Molinari EJ; Whiteaker KL; Davis-Taber R; Scott VE; Cassidy C; Sullivan JP; Carroll WA Br J Pharmacol; 2003 Jan; 138(2):393-9. PubMed ID: 12540531 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel ATP-sensitive K+ channel opener, A-251179, on urinary bladder relaxation and cystometric parameters. Shieh CC; Brune ME; Buckner SA; Whiteaker KL; Molinari EJ; Milicic IA; Fabiyi AC; Daza A; Brioni JD; Carroll WA; Matsushita K; Yamada M; Kurachi Y; Gopalakrishnan M Br J Pharmacol; 2007 Jun; 151(4):467-75. PubMed ID: 17435796 [TBL] [Abstract][Full Text] [Related]
5. K-channel opening activity of ZD6169 and its analogs: effect on 86Rb efflux and 3H-P1075 binding in bladder smooth muscle. Trivedi S; Stetz SL; Potter-Lee L; McConville M; Li JH; Empfield J; Ohnmacht CJ; Russell K; Brown FJ; Trainor DA Pharmacology; 1995 Jun; 50(6):388-97. PubMed ID: 7568338 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of a novel class of naphthyl amide KATP channel openers. Turner SC; Carroll WA; White TK; Brune ME; Buckner SA; Gopalakrishnan M; Fabiyi A; Coghlan MJ; Scott VE; Castle NA; Daza AV; Milicic I; Sullivan JP Bioorg Med Chem Lett; 2003 May; 13(10):1741-4. PubMed ID: 12729655 [TBL] [Abstract][Full Text] [Related]
13. KCO912: a potent and selective opener of ATP-dependent potassium (K(ATP)) channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects. Buchheit KH; Manley PW; Quast U; Russ U; Mazzoni L; Fozard JR Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):220-30. PubMed ID: 11882918 [TBL] [Abstract][Full Text] [Related]
14. Inhibition by protein kinase C of the 86Rb+ efflux and vasorelaxation induced by P1075, a K(ATP) channel opener, in rat isolated aorta. Linde C; Löffler C; Quast U Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):425-32. PubMed ID: 9303583 [TBL] [Abstract][Full Text] [Related]
15. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity. Butera JA; Antane MM; Antane SA; Argentieri TM; Freeden C; Graceffa RF; Hirth BH; Jenkins D; Lennox JR; Matelan E; Norton NW; Quagliato D; Sheldon JH; Spinelli W; Warga D; Wojdan A; Woods M J Med Chem; 2000 Mar; 43(6):1187-202. PubMed ID: 10737752 [TBL] [Abstract][Full Text] [Related]
16. Binding and effects of KATP channel openers in the vascular smooth muscle cell line, A10. Russ U; Metzger F; Kickenweiz E; Hambrock A; Krippeit-Drews P; Quast U Br J Pharmacol; 1997 Nov; 122(6):1119-26. PubMed ID: 9401776 [TBL] [Abstract][Full Text] [Related]
17. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075. Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854 [TBL] [Abstract][Full Text] [Related]
18. Interaction between thiol-modifying agents and P1075, a K(ATP) channel opener, in rat isolated aorta. Linde C; Löffler C; Kessler C; Quast U Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):467-74. PubMed ID: 9349633 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractions. Carroll WA; Altenbach RJ; Bai H; Brioni JD; Brune ME; Buckner SA; Cassidy C; Chen Y; Coghlan MJ; Daza AV; Drizin I; Fey TA; Fitzgerald M; Gopalakrishnan M; Gregg RJ; Henry RF; Holladay MW; King LL; Kort ME; Kym PR; Milicic I; Tang R; Turner SC; Whiteaker KL; Yi L; Zhang H; Sullivan JP J Med Chem; 2004 Jun; 47(12):3163-79. PubMed ID: 15163196 [TBL] [Abstract][Full Text] [Related]